ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.68
+0.16 (1.03%)
At close: Feb 25, 2026, 4:00 PM EST
15.80
+0.12 (0.77%)
After-hours: Feb 25, 2026, 5:53 PM EST
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $3.73 billion as of February 25, 2026. Its market cap has decreased by -5.53% in one year.
Market Cap
3.73B
Enterprise Value
3.75B
1-Year Change
-5.53%
Ranking
Category
Stock Price
$15.68
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $3.73B, an increase of 7,333.87%. That is a compound annual growth rate of 41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 3.69B | -14.91% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 4.16B |
| NewAmsterdam Pharma Company | 4.03B |
| Centessa Pharmaceuticals | 3.94B |
| Viking Therapeutics | 3.85B |
| Corcept Therapeutics | 3.85B |
| Ligand Pharmaceuticals | 3.78B |
| Alumis | 3.66B |
| Legend Biotech | 3.65B |